Browsing: Study

Crimean-Congo hemorrhagic fever virus (CCHFV) is a dangerous virus spread by ticks. It transmits Crimean-Congo hemorrhagic fever (CCHF), a serious disease that has been spreading into new regions in the world. Capable of killing up to 40% of people infected, it currently has no widely approved, highly effective treatments or vaccines. 

JACKSON, Ohio – The State of Ohio Adversity and Resilience (SOAR Study) invites community members and media to attend two Community Conversations that will share research findings directly with the communities that helped make the research possible

Most breakfast advice focuses on what to put on your plate. But a large study of US adults suggests the clock may deserve attention, too: The time you consume your first and last calories of the day could be linked to how long you live

A personalized approach to obesity treatment may help breast cancer survivors improve their long-term health by identifying early which patients need more than behavioral lifestyle intervention alone

DALLAS, Aug. 20, 2026 — A new scientific study found that nearly 8 out of 10 young adult participants, average age 23 years, had cardiovascular-kidney-metabolic syndrome (CKM syndrome), according to new independent research published today in Circulation: Population Health and Outcomes,a peer-reviewed scientific journal of the American Heart Association

Novo Nordisk has begun a late-stage clinical trial to evaluate whether lower doses of its oral pill, Wegovy, can still deliver weight reduction, reported Reuters

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10 to 15% or more. Despite their success, however, scientists have not fully understood how these drugs work in the brain

Potatoes have fed civilizations for thousands of years, but they have done more than that

New research on the experiences of people who took magic mushrooms through Oregon’s homegrown psychedelic industry — the first program of its kind in the U.S. — is offering a largely favorable picture

LONDON, Aug 19 (Reuters) – Danish drugmaker Novo Nordisk is testing lower doses of its Wegovy pill in a new late-stage study to ‌find the lowest dose that still helps patients lose weight, according ‌to a U.S. government database of clinical trials